Heart scans of nearly 40,000 middle-aged and older Britons showed that the heart's main pumping chamber gets smaller with age in both sexes, but more so in women, whose hearts compensate with a faster beat. Experiments in mice and lab-grown heart tissue point to falling sex hormones. The human data are a one-time snapshot and cannot prove cause.
Animal and human data
Old female mice given semaglutide lost noticeably more leg muscle than earlier studies had found in young mice, and old males lost some muscle strength. It is a small three-week study in mice, not yet peer-reviewed, and says nothing yet about what happens in older people.
Animal study
In a small randomized trial at Columbia University, 50 women aged 35 to 45 took a weekly low dose of rapamycin or a placebo for 12 weeks. A year later, a blood marker of the egg supply had fallen slightly less in the rapamycin group, but the posted results include no statistical test, and other measures did not line up. Registry results, not a peer-reviewed paper.
Randomized trial in people
A reanalysis of nearly 34,000 mice from the largest US drug-testing programme for aging found that lifespan gains were about three times larger in the heaviest males than in the lightest. Part of what looks like slowed aging may be the rescue of overfed lab mice. A preprint, in mice only.
Animal study
In a nationwide Polish study of 3,806 people aged 65 and over, those whose blood hemoglobin was even a little below about 13.3 g/dL (women) or 13.9 g/dL (men) were more likely to die over the next ten years, even after other illnesses were taken into account. It is an observational study, and the cut-offs on their own predicted death only weakly.
Observational study in people
In a small randomized trial of colorectal cancer survivors, a year of the diabetes drug metformin modestly lowered NF-κB, a master switch of inflammation, in the healthy lining of the colon. Aspirin had no such effect. The trial fell far short of its planned size, and the authors call the results hypothesis-generating.
Randomized trial in people
In almost 10,000 Canadian adults, researchers measured how far each person's blood chemistry had drifted from that of healthy middle-aged people. The drift split into separate systems, and people who were far off in several systems at once had about three times the risk of dying during follow-up. It is an observational study and a preprint that has not yet been peer-reviewed.
Observational study in people
In about 11,000 American adults, people whose diet included EGCG, a compound found mainly in tea, had blood tests that looked slightly younger and a lower risk of dying over eight years. In worms and mouse liver cells, EGCG worked through peroxisomes, small fat-burning compartments of the cell. The human part is observational, and the mechanism was shown only in worms and cells.
Animal and human data
Using CT scans taken for other reasons in 78,620 patients at nine Japanese hospitals, researchers charted bone density at 25 vertebrae and 24 ribs from age 15 to 100. Density fell with age almost everywhere, and in women the fall was sharpest at about 52 years at every one of the 49 sites. The study is a snapshot of different people at different ages, not a follow-up of the same people, and it is a not yet peer-reviewed preprint.
Observational study in people
In 6,249 US adults, those who ate the most protein relative to their body weight were less likely to show signs of faster biological aging, measured with telomeres and three blood-and-body scores, and were less likely to die during follow-up. The data are a single snapshot of diet from two decades ago, so reverse causation cannot be ruled out, and the study is a not yet peer-reviewed preprint.
Observational study in people
In about 224,000 UK adults followed for nearly 15 years, those who were frail at the start were about 78% more likely to develop coronary artery disease. A pattern of 36 substances in the blood accounted for roughly a fifth of that link in statistical terms. It is an observational study, so it shows links, not causes.
Observational study in people
Fruit flies that got less protein only while they were larvae lived longer as adults, even on a normal diet. The team traced the effect to a storage protein called Lsp2 that carries the larval diet into early adulthood and turns down protein-making. This is careful lab work in flies; it says nothing yet about people.
Animal study
In medical records of hundreds of thousands of adults in Israel and the US, people with severe vitamin D deficiency were more likely to die and to develop several age-related diseases over up to ten years. Pharmacy purchases of vitamin D were linked to lower death rates. The study is observational, so it cannot show that vitamin D itself made the difference, and randomized trials have given mixed results.
Observational study in people
Mice that could eat only six hours a day were partly protected when a hormone was used to stiffen and age their arteries fast, and the protection seemed to come from gut bacteria making acetate. The model imitates vascular aging rather than natural old age, and nothing has been tested in people.
Animal study
In a six-month randomized trial in 114 frail older adults with obesity, diet plus exercise clearly improved physical performance, but adding the diabetes drug metformin gave no extra benefit. The results are posted in a trial registry and have not yet been through peer review as a paper.
Randomized trial in people
Diabetes research on aging has focused on insulin. A Spanish study finds that the pancreas cells making glucagon, insulin's opposite, also change in old mice, and that people with higher glucagon in a Spanish clinical trial were more likely to develop type 2 diabetes. The detailed work is in mice; the human part shows associations only.
Animal and human data
Mice on a 30% calorie-restricted diet had up to 39% fewer new mutations in their liver cells by old age. Oddly, the protection was strongest in the parts of the genome cells don’t use much.
Animal study
Metformin is thought to work partly through an energy sensor called AMPK, but it does many other things too. A compound that switches AMPK on directly extended lifespan in three species, and only when AMPK was there to switch on.
Animal study